M. Teresi

956 total citations
21 papers, 336 citations indexed

About

M. Teresi is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M. Teresi has authored 21 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M. Teresi's work include Cystic Fibrosis Research Advances (7 papers), Asthma and respiratory diseases (5 papers) and Inhalation and Respiratory Drug Delivery (3 papers). M. Teresi is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Asthma and respiratory diseases (5 papers) and Inhalation and Respiratory Drug Delivery (3 papers). M. Teresi collaborates with scholars based in United States, Australia and United Kingdom. M. Teresi's co-authors include William R. Crom, William E. Evans, Joseph Mirro, Mary V. Relling, Kyung Eob Choi, Richard C. Ahrens, David Morgan, Janice L. Launspach, Michael L. Christensen and John H. Rodman and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Cancer and The Journal of Infectious Diseases.

In The Last Decade

M. Teresi

19 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Teresi United States 10 136 70 63 52 49 21 336
M J Gaspar Spain 13 171 1.3× 84 1.2× 61 1.0× 58 1.1× 81 1.7× 34 534
Ming Wen United States 10 156 1.1× 127 1.8× 51 0.8× 138 2.7× 112 2.3× 20 554
W. Kirch Germany 11 34 0.3× 61 0.9× 49 0.8× 46 0.9× 126 2.6× 30 390
S. G. Welshman United Kingdom 10 123 0.9× 105 1.5× 108 1.7× 54 1.0× 22 0.4× 16 358
Eleonora Crascì Italy 10 64 0.5× 36 0.5× 22 0.3× 98 1.9× 29 0.6× 20 314
Rita Maiavacca Italy 13 53 0.4× 33 0.5× 17 0.3× 84 1.6× 15 0.3× 26 340
Nicolas Muruve United States 10 78 0.6× 46 0.7× 125 2.0× 44 0.8× 34 0.7× 21 429
Michelle Brown United Kingdom 8 45 0.3× 42 0.6× 48 0.8× 57 1.1× 77 1.6× 23 344
Abdulrahman Al-Nuaim Saudi Arabia 11 49 0.4× 51 0.7× 73 1.2× 178 3.4× 78 1.6× 24 547
E. Giesbrecht Canada 9 40 0.3× 99 1.4× 104 1.7× 66 1.3× 85 1.7× 19 326

Countries citing papers authored by M. Teresi

Since Specialization
Citations

This map shows the geographic impact of M. Teresi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Teresi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Teresi more than expected).

Fields of papers citing papers by M. Teresi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Teresi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Teresi. The network helps show where M. Teresi may publish in the future.

Co-authorship network of co-authors of M. Teresi

This figure shows the co-authorship network connecting the top 25 collaborators of M. Teresi. A scholar is included among the top collaborators of M. Teresi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Teresi. M. Teresi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fischer, Anthony J., et al.. (2025). Weak Age Restriction Enforcement and Retailer Proliferation Reveal Limits in Tobacco Control Policy. Annals of the American Thoracic Society. 22(10). 1512–1521.
2.
Sokolow, Andrew G., Natalia Jimenez‐Truque, William H. Fissell, et al.. (2024). Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis. The Journal of Infectious Diseases. 231(2). e364–e374. 1 indexed citations
3.
Kapnadak, Siddhartha G., Matthew C. Radey, M. Teresi, et al.. (2023). 57 Bronchoscopy sampling finds that intra-lung bacterial migration contributes to persistent Pseudomonas aeruginosa infection after elexacaftor-tezacaftor-ivacaftor. Journal of Cystic Fibrosis. 22. S31–S31.
4.
Teresi, M., et al.. (2023). Patient and Caregiver Perceptions of Airway Clearance Methods Used for Cystic Fibrosis. Canadian Respiratory Journal. 2023. 1–9. 1 indexed citations
5.
Singh, Sachinkumar B., Douglas B. Hornick, Janice L. Launspach, et al.. (2019). Randomized controlled study of aerosolized hypertonic xylitol versus hypertonic saline in hospitalized patients with pulmonary exacerbation of cystic fibrosis. Journal of Cystic Fibrosis. 19(1). 108–113. 11 indexed citations
6.
Asmus, Michael J., B. A. Stewart, M. Teresi, et al.. (2002). Tobramycin as a Pharmacologic Tracer to Compare Airway Deposition from Nebulizers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(5). 557–563. 9 indexed citations
7.
McCarty, Nael A., T. A. Standaert, M. Teresi, et al.. (2002). A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis*. Pediatric Pulmonology. 33(2). 90–98. 41 indexed citations
8.
Ahrens, Richard C., T. A. Standaert, Janice L. Launspach, et al.. (2002). Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis**. Pediatric Pulmonology. 33(2). 142–150. 48 indexed citations
9.
Ahrens, Richard C., et al.. (2001). Asthma Stability After Oral Prednisone. American Journal of Respiratory and Critical Care Medicine. 164(7). 1138–1145. 12 indexed citations
10.
Asmus, Michael J., et al.. (2001). Multicenter Survey of Pharmacy Faculty and Student Metered-Dose Inhaler Knowledge. Journal of the American Pharmaceutical Association (1996). 41(3). 461–464. 2 indexed citations
11.
Asmus, Michael J., et al.. (2001). In Vitro Characteristics of Tobramycin Aerosol from Ultrasonic and Jet Nebulizers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(5). 534–539. 5 indexed citations
12.
Asmus, Michael J., et al.. (1997). Apparent decrease in population clearance of theophylline: Implications for dosage*. Clinical Pharmacology & Therapeutics. 62(5). 483–489. 1 indexed citations
13.
Teresi, M. & David Morgan. (1994). Attitudes of Healthcare Professionals toward Patient Counseling on Drug-Nutrient Interactions. Annals of Pharmacotherapy. 28(5). 576–580. 17 indexed citations
14.
Teresi, M., Charles E. Riggs, Philippa Webster, et al.. (1993). Bioequivalence of Two Methotrexate Formulations in Psoriatic and Cancer Patients. Annals of Pharmacotherapy. 27(12). 1434–1438. 2 indexed citations
15.
Teresi, M., Daryl J. Murry, & Albert Cornelius. (1993). Ifosfamide-induced hyperpigmentation. Cancer. 71(9). 2873–2875. 9 indexed citations
16.
Teresi, M., William R. Crom, Kyung Eob Choi, Joseph Mirro, & William E. Evans. (1987). Methotrexate bioavailability after oral and intramuscular administration in children. The Journal of Pediatrics. 110(5). 788–792. 61 indexed citations
17.
Sylvester, Robert, et al.. (1987). Excretion of hydroxyurea into milk. Cancer. 60(9). 2177–2178. 21 indexed citations
18.
Crom, William R., et al.. (1987). Simultaneous administration of multiple model substrates to assess hepatic drug clearance. Clinical Pharmacology & Therapeutics. 41(6). 645–650. 29 indexed citations
19.
Crom, William R., John H. Rodman, M. Teresi, et al.. (1987). Pharmacokinetics of Anticancer Drugs in Children. Clinical Pharmacokinetics. 12(3). 168–213. 61 indexed citations
20.
Teresi, M., et al.. (1979). Bovine embryonic skin allografts in treatment of skin ulcers and burns in man.. PubMed. 11(2). 1512–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M J Gaspar Breakdown of academic impact, for papers by Ming Wen Breakdown of academic impact, for papers by W. Kirch Breakdown of academic impact, for papers by S. G. Welshman Breakdown of academic impact, for papers by Eleonora Crascì Breakdown of academic impact, for papers by Rita Maiavacca Breakdown of academic impact, for papers by Nicolas Muruve Breakdown of academic impact, for papers by Michelle Brown Breakdown of academic impact, for papers by Abdulrahman Al-Nuaim Breakdown of academic impact, for papers by E. Giesbrecht
Rankless by CCL
2026